Four Cases of Facial Discoid Lupus Erythematosus Successfully Treated with Topical Pimecrolimus or Tacrolimus
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus. (Ann Dermatol 22(3) 307∼311, 2010)
Abstract
Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus. (Ann Dermatol 22(3) 307∼311, 2010)
참고문헌 (18)
- Rowell NR, "Systemic lupus erythematosus. In:Textbook of dermatology. 6th ed", pp.2461~2500 (1998), Blackwell Science
- Bongu A, "Can morbidity and mortality of SLE be improved?", Best Pract Res Clin Rheumatol, 16, pp.313~332 (2002)
- Fabbri P, "Cutaneous lupus erythematosus:diagnosis and management", Am J Clin Dermatol, 4, pp.449~465 (2003)
- Grassberger M, "A novel anti-inflammatory drug,SDZ ASM 981,for the treatment of skin diseases:in vitro pharmacology", Br J Dermatol, 141, pp.264~273 (1999)
- Eichenfield LF, "Safety and efficacy of pimecrolimus(ASM 981)cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents", J Am Acad Dermatol, 46, pp.495~504 (2002)
- Ruzicka T, "A short-term trial of tacrolimus ointment for atopic dermatitis.European Tacrolimus Multicenter Atopic Dermatitis Study Group", N Engl J Med, 337, pp.816~821 (1997)
- Harper J, "First experience of topical SDZ ASM 981 in children with atopic dermatitis", Br J Dermatol, 144, pp.781~787 (2001)
- Ruzicka T, "Tacrolimus:the drug for the turn of the millennium?", Arch Dermatol, 135, pp.574~580 (1999)
- Grimes PE, "Topical tacrolimus for repigmentation of vitiligo", J Am Acad Dermatol, 47, pp.789~791 (2002)
- Bohm M, "Successful treatment of anogenital lichen sclerosus with topical tacrolimus", Arch Dermatol, 139, pp.922~924 (2003)
- Kanekura T, "Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus", Br J Dermatol, 148, pp.353~356 (2003)
- Druke A, "0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus", J Dermatol Treat, 15, pp.63~64 (2004)
- Yoshimasu T, "Topical FK506(tacrolimus)therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis", Eur J Dermatol, 12, pp.50~52 (2002)
- Walker SL, "The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus", Br J Dermatol, 147, pp.405~406 (2002)
- de la Rosa Carrillo D, "Treatment of chronic discoid lupus erythematosus with topical tacrolimus", Acta Derm Venereol, 84, pp.233~234 (2004)
- Heffernan MP, "0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus", Arch Dermatol, 141, pp.1170~1171 (2005)
- Kreuter A, "Pimecrolimus 1% cream for cutaneous lupus erythematosus", J Am Acad Dermatol, 51, pp.407~410 (2004)
- Tlacuilo-Parra A, "Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus", Rheumatology(Oxford), 44, pp.1564~1568 (2005)